Tiny Health
Austin-based Tiny Health has raised $33 million in a Series B funding round led by B Capital to help it meet growing demand for its at-home microbiome tests.
- Status
- Active
- Funding
- $33M · Series B · Sep 2026
Austin-based Tiny Health has raised $33 million in a Series B funding round led by B Capital to help it meet growing demand for its at-home microbiome tests.
Tiny Health Raises $33M To Explore What Gut Data Can Reveal About Future Health

What they do:
Unleash the potential of genomic medicine using AI
Quick facts:
Funding:
€23.2M · Series B · Oct 2026

What they do:
Omnio, a Umeå-based BioTech startup, has raised an oversubscribed €2.9 million round from existing investors and shareholders to advance its plasminogen-based therapy for hard-to-heal chronic wounds toward clinical…
Quick facts:
HQ: Sweden
Funding:
€2.9M · Oct 2026

What they do:
Empowering women. Period.
Quick facts:
HQ: San Francisco, CA, United States

What they do:
Delivering RNA therapies.
Quick facts:
HQ: London, United Kingdom

What they do:
Clinically-validated ingredients from natural microbes
Quick facts:
HQ: New York, NY, United States

What they do:
Enabling next generation medicines. A comprehensive platform and…
Quick facts:
HQ: San Francisco, CA, United States
Austin-based Tiny Health has raised $33 million in a Series B funding round led by B Capital to help it meet growing demand for its at-home microbiome tests.
Latest round: $33M Series B (Sep 2026).
Similar startups: WhiteLab Genomics, Omnio, and Qvin.